These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10386239

  • 1. The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients.
    Ogawa S, Takeuchi K, Sugimura K, Sato C, Fukuda M, Lee R, Ito S, Sato T.
    Clin Exp Pharmacol Physiol; 1999; 26(5-6):461-4. PubMed ID: 10386239
    [Abstract] [Full Text] [Related]

  • 2. Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy.
    Tajiri Y, Umeda F, Inoguchi T, Kunisaki M, Nawata H, Ninomiya H, Asano T.
    Diabetes Res; 1990 Mar; 13(3):145-50. PubMed ID: 2091882
    [Abstract] [Full Text] [Related]

  • 3. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC, Borgatti R, Cacciari M, Lenzi P, Marinelli M, Stipo L.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [Abstract] [Full Text] [Related]

  • 4. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [Abstract] [Full Text] [Related]

  • 5. Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia.
    Higashi Y, Miyazaki M, Goto C, Sanada H, Sueda T, Chayama K.
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):56-61. PubMed ID: 19834330
    [Abstract] [Full Text] [Related]

  • 6. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T, Kameda H, Ichikawa Y, Tojo T, Homma M.
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [Abstract] [Full Text] [Related]

  • 7. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS.
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
    [Abstract] [Full Text] [Related]

  • 8. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F, Ozguner F, Yilmaz HR, Uz E, Dündar B.
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(1-2):95-101. PubMed ID: 16445706
    [Abstract] [Full Text] [Related]

  • 9. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
    Navarro JF, Mora C, Muros M, García J.
    J Am Soc Nephrol; 2005 Jul; 16(7):2119-26. PubMed ID: 15917336
    [Abstract] [Full Text] [Related]

  • 10. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P, Eiam-Ong S, Suwanwalaikorn S.
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effects of sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, supplemented with pioglitazone on diabetic model mice.
    Iizuka K, Hamaue N, Machida T, Hirafuji M, Tsuji M.
    Endocr Res; 2009 Feb; 34(1-2):18-30. PubMed ID: 19557588
    [Abstract] [Full Text] [Related]

  • 12. Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization.
    Michel F, Silvestre JS, Waeckel L, Corda S, Verbeuren T, Vilaine JP, Clergue M, Duriez M, Levy BI.
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):488-93. PubMed ID: 16385086
    [Abstract] [Full Text] [Related]

  • 13. Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria.
    Brocco E, Fioretto P, Mauer M, Saller A, Carraro A, Frigato F, Chiesura-Corona M, Bianchi L, Baggio B, Maioli M, Abaterusso C, Velussi M, Sambataro M, Virgili F, Ossi E, Nosadini R.
    Kidney Int Suppl; 1997 Dec; 63():S40-4. PubMed ID: 9407419
    [Abstract] [Full Text] [Related]

  • 14. Levels of stable metabolites of prostacyclin and thromboxane A2 and their ratio in normotensive and preeclamptic pregnant women during the antepartum and postpartum periods.
    Malatyalioğlu E, Adam B, Yanik FF, Kökçü A, Alvur M.
    J Matern Fetal Med; 2000 Dec; 9(3):173-7. PubMed ID: 10914626
    [Abstract] [Full Text] [Related]

  • 15. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
    Miyazaki M, Higashi Y, Goto C, Chayama K, Yoshizumi M, Sanada H, Orihashi K, Sueda T.
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):221-7. PubMed ID: 17438407
    [Abstract] [Full Text] [Related]

  • 16. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
    Lazarevic G, Antic S, Vlahovic P, Djordjevic V, Zvezdanovic L, Stefanovic V.
    Ren Fail; 2007 Apr; 29(2):199-205. PubMed ID: 17365936
    [Abstract] [Full Text] [Related]

  • 17. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
    Kobayashi S, Satoh M, Namikoshi T, Haruna Y, Fujimoto S, Arakawa S, Komai N, Tomita N, Sasaki T, Kashihara N.
    Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
    [Abstract] [Full Text] [Related]

  • 18. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K, Ikarashi T.
    Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
    [Abstract] [Full Text] [Related]

  • 19. Chronic 5-HT2 receptor blockade unmasks the role of 5-HT1F receptors in the inhibition of rat cardioaccelerator sympathetic outflow.
    García-Pedraza JÁ, Hernández-Abreu O, García M, Morán A, Villalón CM.
    Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
    [Abstract] [Full Text] [Related]

  • 20. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F, Davì G, Consoli A, Cipollone F, Mezzetti A, Falco A, Taraborelli T, Devangelio E, Ciabattoni G, Basili S, Patrono C.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):391-7. PubMed ID: 16412866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.